NCT05627739View on ClinicalTrials.gov

A Study of Mycophenolate Mofetil Combined With Glucocorticoid Therapy in Relapse Vogt-Koyanagi-Harada Disease

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

December 1, 2024

Study Completion Date

December 1, 2025

Conditions

Vogt-Koyanagi-Harada DiseaseMycophenolate Mofetil

Interventions

DRUG

Mycophenolate Mofetil

Glucocorticoid is started at a dose of 0.5-0.8 mg/kg/day, and 60 mg daily was the highest dose. Mycophenolate mofetilwas is started at a dose of 0.5-1.0g bid.

Trial Locations (1)

300000

RECRUITING

xiaomin Zhang, Tianjin

All Listed Sponsors

lead

Tianjin Medical University

OTHER